Astellas Pharma China, Inc.

ACTIVE

No.6A3, No.10 Road, Economic Technology Development Zone, 沈阳市, 辽宁省, Chinawww.astellas.com.cnSubsidiaryEstablished: 1994-10-14

Part of astellas (china) investment co., ltd.

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1994

Overview

Trial Phase Distribution

Phase

Trials

Phase 4

42.9%

Phase 3

25.0%

Phase 1

17.9%

Phase 2

3.6%

Trial Status Distribution

Active, not recruiting

7.1%

Completed

71.4%

Terminated

14.3%

Clinical Trials

Trials sponsored by this organization (28)

A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Phase 4

Completed

interventional

Jan 202255 participants

A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Phase 4

Completed

interventional

Dec 202156 participants

A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy

Phase 2

Completed

interventional

Jul 202140 participants

A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects

Phase 1

Completed

interventional

Mar 202116 participants

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

Phase 4

Completed

interventional

Jan 2021249 participants

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Phase 4

Completed

interventional

Sep 202024 participants

A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause

Phase 3

Completed

interventional

Jul 2020150 participants

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Phase 3

Completed

interventional

Mar 2020302 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

Back to Organizations